We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now


It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

PTPI Petros Pharmaceuticals Inc

-0.05 (-3.62%)
Last Updated: 12:14:12
Delayed by 15 minutes


Draw Mode:

Volume 55,886
Bid Price 1.33
Ask Price 1.35
News -
Day High 1.43


52 Week Range


Day Low 1.25
Share Name Share Symbol Market Stock Type
Petros Pharmaceuticals Inc PTPI NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
-0.05 -3.62% 1.33 12:14:12
Open Price Low Price High Price Close Price Previous Close
1.34 1.25 1.43 1.38
Trades Shares Traded VWAP Financial Volume Average Volume 52 Week Range
327 55,886 US$ 1.34 US$ 74,755 - 0.9172 - 9.54
Last Trade Type Quantity Price Currency
12:14:12 18 US$ 1.33 USD

Petros Pharmaceuticals Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
2.97M 2.20M - 9.38M -20.04M -9.10 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Petros Pharmaceuticals News

Date Time Source News Article
11/30/202315:07Edgar (US Regulatory)Form ARS - Annual Report to Security Holders
11/30/202315:05Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statements
11/15/202316:11Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/15/202316:00Edgar (US Regulatory)Form NT 10-Q - Notification of inability to timely file Form..
10/02/202307:00Edgar (US Regulatory)Form 8-K - Current report
9/19/202315:36Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]
9/15/202316:16Edgar (US Regulatory)Form S-3/A - Registration statement under Securities Act of..
9/15/202315:22Edgar (US Regulatory)Form 8-K - Current report
8/25/202316:08Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statements
8/15/202316:03Edgar (US Regulatory)Form 8-K - Current report
8/15/202316:01Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statements
8/14/202316:03Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No PTPI Message Board. Create One! See More Posts on PTPI Message Board See More Message Board Posts

Historical PTPI Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week1.431.631.251.36254,805-0.10-6.99%
1 Month1.,9710.053.91%
3 Months1.802.131.201.5480,998-0.47-26.11%
6 Months2.154.741.203.32219,871-0.82-38.14%
1 Year2.409.540.91724.73779,381-1.07-44.58%
3 Years35.2059.5990.917226.532,078,136-33.87-96.22%
5 Years18.0059.5990.917226.542,059,557-16.67-92.61%

Petros Pharmaceuticals Description

Petros Pharmaceuticals Inc is a men's health pharmaceutical company. It focuses on identifying, developing, acquiring, and commercializing innovative therapeutics for men's health issues including erectile dysfunction, peyronie's disease, hormone health and substance use disorders. The company's operating segment includes Prescription Medications and Medical Devices. It generates maximum revenue from the Prescription Medications segment. The Prescription Medications segment consists primarily of operations related to Stendra, which is sold generally in the United States, and H100 for the treatment of Peyronie's disease.

Your Recent History

Delayed Upgrade Clock

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

Support: 1-888-992-3836 |